Microtubule affinity‐regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non‐small cell lung cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|137|9|2072-2082

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.9, 2015-11, pp. : 2072-2082

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ATF2 contributes to cisplatin resistance in non‐small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 136, Iss. 11, 2015-06 ,pp. : 2598-2609

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pretreatment Pokemon Level as a Predictor of Response to Cisplatin and Paclitaxel in Patients with Unresectable Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 38, Iss. 10, 2015-0 ,pp. : 496-502

Karger

Access to resources Recommend Favorite

Vinorelbine and Alternating Cisplatin and Ifosfamide in the Treatment of Non-Small Cell Lung Cancer

By  

Oncology, Vol. 58, Iss. 1, 2000-01 ,pp. : 25-30

Karger

Access to resources Recommend Favorite

Challenges in the Management of EGFR-Mutated Non-Small Cell Lung Cancer Patients with Acquired Resistance to Tyrosine Kinase Inhibitors

By  

Oncology, Vol. 87, Iss. 2, 2014-07 ,pp. : 83-94

Karger

Access to resources Recommend Favorite

Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor

By  

CANCER, Vol. 119, Iss. 24, 2013-12 ,pp. : 4325-4332

John Wiley & Sons Inc

Access to resources Recommend Favorite